The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for tapinarof cream, 1% in the treatment of atopic dermatitis in adults and ...

Learn about the benefits and risks of probiotic supplements and how to choose the best one for your health goals.

The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...

Thankfully, many skincare brands have taken into account the large segment of the population who struggle with sensitive skin ...

Organon, which is seeking approval of Vtama as a treatment for atopic dermatitis, said the FDA set a new target action date of March 12 for a decision after requesting the final datasets and ...

The U.S. Food and Drug Administration (FDA) announced the target action date of its review of the sNDA for VTAMA (tapinarof) cream, 1% has changed.

Organon (OGN) stock on watch as FDA delays a potential label expansion for its VTAMA cream, impacting 2025 EBITDA margin and ...

Revolutionizing Home and Commercial Cleaning with Aqueous Ozone Solutions that are hypoallergenic & eco-friendly ...

If not controlled with the above measures, your eczema might require prescription treatments like corticosteroids or even ...

Prior treatment use did not affect the efficacy or safety of topical ruxolitinib cream 1.5% for up to 52 weeks among patients with atopic dermatitis.

Occupational contact dermatitis was common among construction workers, with metals, epoxy resin, and rubber identified as common etiological sources.

Despite winning an alopecia areata approval for its drug Leqselvi in July, Sun Pharma will have to wait a while longer to ...